Hyun Chang

2.1k total citations
67 papers, 1.5k citations indexed

About

Hyun Chang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hyun Chang has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 24 papers in Surgery. Recurrent topics in Hyun Chang's work include Lung Cancer Treatments and Mutations (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). Hyun Chang is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). Hyun Chang collaborates with scholars based in South Korea, Ethiopia and Puerto Rico. Hyun Chang's co-authors include Nayoung Kim, Cheol Min Shin, Jin Won Kim, Hyun Chae Jung, Jong Seok Lee, Keun‐Wook Lee, Yu Jung Kim, Ryoung Hee Nam, Hye Seung Lee and Dong Ho Lee and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Hyun Chang

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyun Chang South Korea 21 614 552 509 360 253 67 1.5k
Mary Falzon United Kingdom 21 679 1.1× 292 0.5× 371 0.7× 275 0.8× 280 1.1× 45 1.4k
Kyueng‐Whan Min South Korea 22 387 0.6× 553 1.0× 323 0.6× 597 1.7× 304 1.2× 136 1.6k
Eizaburo Sasatomi United States 26 335 0.5× 500 0.9× 591 1.2× 321 0.9× 187 0.7× 77 1.8k
Alberto Marchet Italy 28 1.8k 2.9× 562 1.0× 1.4k 2.7× 214 0.6× 247 1.0× 75 2.7k
Daniel Reim Germany 20 877 1.4× 448 0.8× 643 1.3× 234 0.7× 115 0.5× 73 1.7k
Annalisa Altimari Italy 20 259 0.4× 389 0.7× 269 0.5× 380 1.1× 255 1.0× 72 1.1k
Feng Qian China 25 678 1.1× 450 0.8× 292 0.6× 641 1.8× 318 1.3× 80 1.6k
Tomonobu Gion Japan 26 412 0.7× 746 1.4× 1.3k 2.6× 311 0.9× 339 1.3× 88 2.8k
Weijian Guo China 15 572 0.9× 589 1.1× 262 0.5× 304 0.8× 170 0.7× 72 1.4k

Countries citing papers authored by Hyun Chang

Since Specialization
Citations

This map shows the geographic impact of Hyun Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyun Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyun Chang more than expected).

Fields of papers citing papers by Hyun Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyun Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyun Chang. The network helps show where Hyun Chang may publish in the future.

Co-authorship network of co-authors of Hyun Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Hyun Chang. A scholar is included among the top collaborators of Hyun Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyun Chang. Hyun Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Hyun, et al.. (2025). Comparative Analysis of Large Language Models for Answering Cancer-Related Questions in Korean. Yonsei Medical Journal. 66(7). 405–405. 1 indexed citations
2.
3.
Lim, Soyeon, et al.. (2022). Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model. Investigative and Clinical Urology. 64(1). 74–74. 7 indexed citations
4.
Park, Ji Hyun, Sang Hoon Chun, Yun‐Gyoo Lee, et al.. (2020). Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12. Journal of Cancer Research and Clinical Oncology. 146(12). 3359–3369. 14 indexed citations
5.
Lee, Yun‐Gyoo, Hyun Chang, Bhumsuk Keam, et al.. (2020). Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12. Cancer Research and Treatment. 53(3). 671–677. 20 indexed citations
6.
Yun, Mi Ran, You Won Lee, Chae Won Park, et al.. (2019). Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer. EMBO Molecular Medicine. 11(12). e10581–e10581. 46 indexed citations
7.
8.
Chang, Hyun, Sun Min Lim, Hye Ryun Kim, et al.. (2017). P1.02-030 Performance Evaluation of ALK/ROS1 Dual Break Apart FISH Probe Kit (RUO) in Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S505–S506. 1 indexed citations
9.
Kim, Se Hyun, Mi Jung Kim, Yu Jung Kim, et al.. (2017). Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy. Medicine. 96(42). e8176–e8176. 16 indexed citations
10.
Pyo, Kyoung‐Ho, Sun Min Lim, Hye Ryun Kim, et al.. (2016). Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK –Positive Human Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(3). 491–500. 20 indexed citations
11.
Shin, Cheol Min, Nayoung Kim, Hyun Chang, et al.. (2016). Follow-Up Study on CDX1 and CDX2 mRNA Expression in Noncancerous Gastric Mucosae After Helicobacter pylori Eradication. Digestive Diseases and Sciences. 61(4). 1051–1059. 19 indexed citations
12.
Lee, Jeong‐Ok, Ju Hyun Lee, Soyeon Ahn, et al.. (2014). Prevalence and Risk Factors for Iron Deficiency Anemia in the Korean Population: Results of the Fifth Korea National Health and Nutrition Examination Survey. Journal of Korean Medical Science. 29(2). 224–224. 53 indexed citations
13.
Kim, Miso, Hyun Chang, Hee Chul Yang, et al.. (2014). Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World Journal of Surgical Oncology. 12(1). 37–37. 32 indexed citations
14.
Kim, Jin Won, Se Hyun Kim, Hyun Chang, et al.. (2014). p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines. Cancer Research and Treatment. 47(3). 501–508. 32 indexed citations
15.
Kim, Yeon Wook, Jin Won Kim, Jungsil Lee, et al.. (2014). Metastatic testicular tumor presenting as a scrotal hydrocele: An initial manifestation of pancreatic adenocarcinoma. Oncology Letters. 7(6). 1793–1795. 7 indexed citations
16.
Kim, Jin Won, Keun‐Wook Lee, Hyun Chang, et al.. (2013). The early discontinuation of palliative chemotherapy in older patients with cancer. Supportive Care in Cancer. 22(3). 773–781. 39 indexed citations
17.
Chang, Hyun, Sun Young Rha, Hei‐Cheul Jeung, et al.. (2013). Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells. International Journal of Molecular Medicine. 31(5). 1202–1208. 14 indexed citations
18.
19.
Moon, Yong Wha, Sun Young Rha, Hei‐Cheul Jeung, et al.. (2010). Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design. Cancer Chemotherapy and Pharmacology. 66(4). 797–805. 23 indexed citations
20.
Moon, Yong Wha, Sun Young Rha, Sang Joon Shin, et al.. (2009). Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators. Journal of Cancer Research and Clinical Oncology. 136(3). 387–394. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Falzon Breakdown of academic impact, for papers by Kyueng‐Whan Min Breakdown of academic impact, for papers by Eizaburo Sasatomi Breakdown of academic impact, for papers by Alberto Marchet Breakdown of academic impact, for papers by Daniel Reim Breakdown of academic impact, for papers by Annalisa Altimari Breakdown of academic impact, for papers by Feng Qian Breakdown of academic impact, for papers by Tomonobu Gion Breakdown of academic impact, for papers by Weijian Guo
Rankless by CCL
2026